This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Josephine Felber - Innovator in HBV Treatment
Introduction: Josephine Felber is an accomplished inventor based in Basel, Switzerland. She is currently associated with F. Hoffmann-La Roche AG, where she contributes to innovative research in the field of biotechnology. Despite having no granted patents to her name, her work in developing therapeutic solutions is noteworthy.
Latest Patent Applications: Josephine Felber's recent patent application is titled "Oligonucleotides for Modulating RTEL1 Expression." This invention focuses on a RTEL1 inhibitor intended for the treatment of HBV infections, particularly chronic HBV infections. The application details the use of RTEL1 inhibitors to destabilize cccDNA, such as HBV cccDNA. Additionally, it includes antisense oligonucleotides that are complementary to RTEL1 and capable of reducing RTEL1 mRNA. The invention also encompasses a pharmaceutical composition and its application in the treatment and/or prevention of HBV infections.
Conclusion: Josephine Felber's contributions to the field of biotechnology, particularly in the treatment of HBV infections, highlight her innovative spirit and dedication to advancing medical science. Her ongoing research and patent applications reflect her commitment to finding effective solutions for complex health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile